ShowNotes
A Mississauga company that makes H1N1 flu shots is about to wrap up a study looking into an alarming rise in the number of cases of narcolepsy in Scandinavian children who've had the shot.
- Glaxo-Smith-Kline launched the study after Finland reported a risk of the sleep disorder nine times higher in inoculated children between the ages of 4 and 19
